Company Overview and News

 
Alkane Resources is an award winning gold miner with a multi-commodity construction-ready project

2018-03-26 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has used its cash-generating Tomingley Gold Operation (TGO) in New South Wales to advance its Dubbo Project to a construction-ready stage.

 
Alkane Resources wins mining operation of the year award

2018-03-20 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) was recently awarded mining operation of the year as part of the New South Wales Minerals Council Suppliers Awards.

 
Alkane Resources develops new process to produce hafnium

2018-01-17 proactiveinvestors.com.au
Alkane Resources Limited (ASX:ALK) has developed a high‐purity hafnium dioxide product that will have use in production of superalloys and aerospace alloys.

 
Alkane Resources confirms depth potential at Tomingley Gold Operations

2017-12-11 proactiveinvestors.com.au
Alkane Resources Limited (ASX:ALK) has confirmed that mineralisation continues below the Wyoming One open pit at the Tomingley Gold Operations (TGO) in New South Wales.

 
Alkane Resources (ANLKY) Investor Presentation - Slideshow

2017-12-01 seekingalpha
The following slide deck was published by Alkane Resources Ltd. ADR in conjunction with this event.

 
Alkane Resources drill results may extend open pit to underground

2017-11-17 proactiveinvestors.com.au
Alkane Resources (ASX:ALK) has received drill assays from the Wyoming One open-pit, which is within the Tomingley Gold Operations (TGO) located in New South Wales.

 
Alkane Resources maintains focus to refresh board

2017-10-17 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK,OTCQX:ANLKY) is a multi-commodity mining company focussed in the central west of New South Wales.

 
Alkane Resources continues strategy to refresh board with new appointments

2017-10-17 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK,OTCQX:ANLKY) is a multi-commodity mining company focussed in the central west of New South Wales.

 
Alkane Resources doubles Proved Ore Reserves of Dubbo Project

2017-09-20 proactiveinvestors.com.au
Alkane Resources (ASX:ALK) has independently re-estimated the Toongi deposit within the Dubbo Project located in New South Wales.

 
Alkane Resources reveals epithermal style gold from Northern Molong Porphyry Project

2017-08-15 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has revealed results from its first diamond holes at the Northern Molong Porphyry Project, which is an exploration project where previous drilling has outlined a large low grade gold-copper porphyry system.

 
Alkane Resources discovers more gold at Tomingley after record production quarter

2017-08-10 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has discovered more gold at the El Paso prospect, which is located south of the gold producing Tomingley mine site in New South Wales.

 
Alkane Resources confirms a record June quarter for gold production

2017-07-19 proactiveinvestors.com.au
Alkane Resources (ASX:ALK) has produced record gold production during the June quarter of 27,924 ounces at an all-in sustaining cash cost (AISC) of A$906 per ounce.

 
The Gold Report Examines Australian Miner's Revenue Stream Still Going Strong at Tomingley

2017-07-03 marketwired
SAN FRANCISCO, CA--(Marketwired - July 03, 2017) - With gold production progressing better than expected, this miner has revised its guidance for FY/17.

 
Alkane Resources upgrades gold production guidance

2017-06-27 proactiveinvestors.com.au
Alkane Resources (ASX:ALK) has upgraded its expected gold production for FY2017 thanks to strong operating performance across the months of April and May.

 
The Gold Report Examines Rare Earths and Gold Projects Advancing in Australia

2017-05-30 marketwired
SAN FRANCISCO, CA--(Marketwired - May 30, 2017) - A recent report by Edison Investment Research has Alkane Resources Ltd. (ASX: ALK) (OTCQX: ANLKY) back on track at its Tomingley Gold Operations after disruptive rains, and development is continuing at the multi-commodity Dubbo Project.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...